Rifampicin

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 6 records

Rifampicin 2 markets · 6 records Forms
Filters
MarketCZ 5LV 1
Kind

CZ 5 records · 5 shown of 5 Source Státní ústav pro kontrolu léčiv (S · Data as of 2026-11-01

Only this ingredient

  • 300 mgcapsuleBENEMICIN also in LV
  • 616.4 mg per mL / per unit basis not statedinjectionEREMFATEREMFAT I.V. 600 MG
  • 150 mgcapsuleBENEMICIN

Combination products containing this ingredient

  • 75 mgtablet CombinationIsoniazid 50 mg + Rifampicin 75 mgRifampicin 150mg / Isoniazid 100mg tablets
  • 75 mgtablet CombinationIsoniazid 50 mg + Pyrazinamide 150 mg + Rifampicin 75 mgRIFAMPICIN 75MG + ISONIAZID 50MG + PYRAZINAMIDE 150MG

LV 1 records · 1 shown of 1 Source Zāļu valsts aģentūra (ZVA) · Data as of 2026-11-11

Only this ingredient

  • 300 mgcapsuleBenemicin 300 mg capsules, hardBenemicin 300 mg cietās kapsulas also in CZ

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.